Infectious diseases and STIs Flashcards
Causes of non-falciparum malaria
Most common: Plasmodium vivax- Central America, indian subcontinent
Plasmodium ovale - Africaand Plasmodium malariae
Plasmodium knowlesi is another non-falciparum species which causes clinical pathology, found predominantly in South East Asia.
Features of non-falciparum malaria
general features of malaria: fever, headache, splenomegaly
Plasmodium vivax/ovale: cyclical fever every 48 hours. Plasmodium malariae: cyclical fever every 72 hours
Plasmodium malariae: is associated with nephrotic syndrome.
Ovale and vivax malaria have a hypnozoite stage and may therefore relapse following treatment.
Treatment of non-falciparum malaria
in areas which are known to be chloroquine-sensitive then WHO recommend either an artemisinin-based combination therapy (ACT) or chloroquine
in areas which are known to be chloroquine-resistant an ACT should be used
ACTs should be avoided in pregnant women
patients with ovale or vivax malaria should be given primaquine following acute treatment with chloroquine to destroy liver hypnozoites and prevent relapse
Features of infectious mononucleosis
Triad
The classic triad of sore throat, pyrexia and lymphadenopathy is seen in around 98% of patients:
sore throat
lymphadenopathy: may be present in the anterior and posterior triangles of the neck, in contrast to tonsillitis which typically only results in the upper anterior cervical chain being enlarged
pyrexia
Other features of infectious mononucleosis
malaise, anorexia, headache
palatal petechiae
splenomegaly - occurs in around 50% of patients and may rarely predispose to splenic rupture
hepatitis, transient rise in ALT
lymphocytosis: presence of 50% lymphocytes with at least 10% atypical lymphocytes
haemolytic anaemia secondary to cold agglutins (IgM)
a maculopapular, pruritic rash develops in around 99% of patients who take ampicillin/amoxicillin whilst they have infectious mononucleosis
Diagnosing infectious mononucleosis
heterophil antibody test (Monospot test) - NICE guidelines suggest FBC and Monospot in the 2nd week of the illness to confirm a diagnosis of glandular fever.
Management of infectious mononucleosis
rest during the early stages, drink plenty of fluid, avoid alcohol
simple analgesia for any aches or pains
consensus guidance in the UK is to avoid playing contact sports for 8 weeks after having glandular fever to reduce the risk of splenic rupture
Overview of Hep E
RNA hepevirus
spread by the faecal-oral route
incubation period: 3-8 weeks
common in Central and South-East Asia, North and West Africa, and in Mexico
causes a similar disease to hepatitis A, but carries a significant mortality (about 20%) during pregnancy
does not cause chronic disease or an increased risk of hepatocellular cancer
a vaccine is currently in development, but is not yet in widespread us
Difference between falciparum and non-falciparum malaria
plasmodium falciparum is more deadly
Plasmodium vivax is more easily transmissable
What is mycoplasma pneumoniae?
Mycoplasma pneumoniae is a cause of atypical pneumonia which often affects younger patients. It is associated with a number of characteristic complications such as erythema multiforme and cold autoimmune haemolytic anaemia. Epidemics of Mycoplasma pneumoniae classically occur every 4 years. It is important to recognise atypical pneumonia as it may not respond to penicillins or cephalosporins due to it lacking a peptidoglycan cell wall.
Features of mycopplasma pneumoniae
the disease typically has a prolonged and gradual onset
flu-like symptoms classically precede a dry cough
bilateral consolidation on x-ray
complications may occur as below
Complications of mycoplasma pneumoniae
cold agglutins (IgM): may cause an haemolytic anaemia, thrombocytopenia
erythema multiforme, erythema nodosum
meningoencephalitis, Guillain-Barre syndrome and other immune-mediated neurological diseases
bullous myringitis: painful vesicles on the tympanic membrane
pericarditis/myocarditis
gastrointestinal: hepatitis, pancreatitis
renal: acute glomerulonephritis
Diagnosis of mycoplasma pneumoniae
mycoplasma serology
positive cold agglutinins
Management of mycoplasma pneumoniae
doxycycline or a macrolide (e.g. erythromycin/clarithromycin)
Common features of legionella and mycoplasma pneumoniae
atypical pneumonia
flu like symptoms
derranged LFTs
Treat with macrolide
GI Abx
Salmonella (non-typhoid)
Ciprofloxacin
GI abx
Shigella
Ciprofloxacin
GI Abx
Campylobacter
Clarithromycin
What is cytomegalovirus
Cytomegalovirus (CMV) is one of the herpes viruses. It is thought that around 50% of people have been exposed to the CMV virus although it only usually causes disease in the immunocompromised, for example people with HIV or those on immunosuppressants following organ transplantation.
Histological features of cytomegalovirus
infected cells have a ‘Owl’s eye’ appearance due to intranuclear inclusion bodies
Congenital cytomegalovirus
features include growth retardation, pinpoint petechial ‘blueberry muffin’ skin lesions, microcephaly, sensorineural deafness, encephalitiis (seizures) and hepatosplenomegaly
Cytomegalovirus infectious mononucleosis
infectious mononucelosis-like illness
may develop in immunocompetent individuals
CMV retinitis
common in HIV patients with a low CD4 count (< 50)
presents with visual impairment e.g. ‘blurred vision’. Fundoscopy shows retinal haemorrhages and necrosis, often called ‘pizza’ retina
IV ganciclovir is the treatment of choice
HIV neurocomplications
Focal Lesions
Toxoplasmosis
accounts for around 50% of cerebral lesions in patients with HIV
constitutional symptoms, headache, confusion, drowsiness
CT: usually single or multiple ring enhancing lesions, mass effect may be seen
management: sulfadiazine and pyrimethamine